Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Tissue Engineering

Background:

• Mesenchymal stem cells (MSCs), particularly adipose-derived stem cells (ASCs), are multipotent progenitors with high proliferation and self-renewal capabilities.
• ASCs are abundant in adipose tissue, making them an attractive source for regenerative medicine applications.
• Despite their immunomodulatory and regenerative properties, clinical trial outcomes for ASC-based therapies have been inconsistent.

Purpose of the Study:

• To review the characteristic features of adipose-derived stem cells (ASCs).
• To explore the regenerative potential of ASCs.
• To analyze the clinical applications and outcomes of ASCs in various clinical trials.

Main Methods:

• Literature review of recent developments in stem cell isolation and expansion.
• Analysis of characteristic features of ASCs, including proliferation, self-renewal, and differentiation potential.
• Evaluation of clinical trial data regarding the effectiveness and applications of ASCs.

Main Results:

• ASCs possess unique characteristics beneficial for tissue engineering and regenerative medicine.
• Challenges such as lack of universal markers, population heterogeneity, and varied protocols impede precise analysis and consistent clinical results.
• Conflicting data in literature highlights the need for standardized methodologies.

Conclusions:

• Standardization of ASC isolation and expansion protocols is crucial for consistent therapeutic outcomes.
• Further research is needed to fully elucidate ASC properties and optimize their clinical application.
• Addressing heterogeneity and analytical challenges will enhance the translational success of ASC-based regenerative therapies.